These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3887877)

  • 1. Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study.
    Lidell C; Rehnqvist N; Sjögren A; Yli-Uotila RJ; Rønnevik PK
    Am Heart J; 1985 May; 109(5 Pt 1):970-5. PubMed ID: 3887877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.
    Anderson JL
    Am J Cardiol; 1990 Jan; 65(2):37A-42A; discussion 51A-52A. PubMed ID: 2403734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions.
    Lee WK; Strong JM; Kehoe RF; Dutcher JS; Atkinson AJ
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):508-14. PubMed ID: 776488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.
    Jordaens LJ; Colardyn F; Clement DL
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):155-61. PubMed ID: 2487531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia.
    Kubac G; Klinke WP; Grace M
    Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of sotalol for life-threatening ventricular arrhythmias.
    Roden DM
    Am J Cardiol; 1993 Aug; 72(4):51A-55A. PubMed ID: 8346727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.
    Myerburg RJ; Kessler KM; Kiem I; Pefkaros KC; Conde CA; Cooper D; Castellanos A
    Circulation; 1981 Aug; 64(2):280-90. PubMed ID: 7249296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term experience with sotalol in the treatment of complex ventricular arrhythmias.
    Anastasiou-Nana MI; Anderson JL; Askins JC; Gilbert EM; Nanas JN; Menlove RL
    Am Heart J; 1987 Aug; 114(2):288-96. PubMed ID: 3604885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sotalol versus class I and II antiarrhythmic agents.
    Hanyok JJ; MacNeil DJ
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():603-11. PubMed ID: 2275890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-ranging trial of N-acetylprocainamide in patients with premature ventricular contractions.
    Atkinson AJ; Lee WK; Quinn ML; Kushner W; Nevin MJ; Strong JM
    Clin Pharmacol Ther; 1977 May; 21(5):575-87. PubMed ID: 322922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
    Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
    Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.
    Ruder MA; Ellis T; Lebsack C; Mead RH; Smith NA; Winkle RA
    J Am Coll Cardiol; 1989 Jan; 13(1):145-52. PubMed ID: 2909562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term sotalol therapy in patients with ventricular arrhythmias.
    Mary-Rabine L; Soumagne D; Stiels B
    Acta Cardiol; 1986; 41(2):89-97. PubMed ID: 2424202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sotalol on exercise-induced ventricular arrhythmias.
    Petzl DH; Probst P; Glogar D; Schuster E
    Eur Heart J; 1988 Mar; 9(3):265-70. PubMed ID: 3383867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sotalol: a new beta-adrenergic blocker for ventricular arrhythmias.
    Cavusoglu E; Frishman WH
    Prog Cardiovasc Dis; 1995; 37(6):423-40. PubMed ID: 7777671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
    Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.